Molecular assessment of atpase6 mutations associated with artemisinin resistance among unexposed and exposed Plasmodium falciparum clinical isolates to artemisinin-based combination therapy

Malaria Journal

Volumn 11, Issue , 2012, Pages

  Zakeri, Sedigheh ^a   Hemati, Samaneh ^b   Pirahmadi, Sakineh ^a   Afsharpad, Mandana ^a   Raeisi, Ahmad ^c,d   Djadid, Navid D ^a  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b Khatam University   (Iran)

^c MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ARTEMISININ; ARTESUNATE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHILD; GENE DOSAGE; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

ADENOSINE TRIPHOSPHATASES; ANIMALS; ANTIMALARIALS; ARTEMISININS; BASE SEQUENCE; DNA, PROTOZOAN; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; GENE DOSAGE; GENES, PROTOZOAN; HAPLOTYPES; HUMANS; IRAN; MALARIA, FALCIPARUM; MUTATION; PLASMODIUM FALCIPARUM; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTOZOAN PROTEINS;

EID: 84868601175     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-11-373     Document Type: Article

References (42)

1. Epidemiology of drug-resistant malaria. Wongsrichanalai C, Pickard AL, Wernsdorfer WH, Meshnick SR, Lancet Infect Dis 2002 2 209 218 10.1016/S1473-3099(02)00239-6 11937421 (Pubitemid 34464751)
2. Antimalarial drug resistance, artemisinin-based combination therapy, and the contribution of modeling to elucidating policy choices. Yeung S, Pongtavornpinyo W, Hastings IM, Mills AJ, White NJ, AmJ Trop Med Hyg 2004 71 179 186 (Pubitemid 39121321)
3. Artemisinin resistance in Plasmodium falciparum malaria. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NP, Lindegardh N, Socheat D, White NJ, N Engl J Med 2009 361 455 467 10.1056/NEJMoa0808859 19641202
4. Artemisinin resistance in Cambodia 1 (ARC1) Study Consortium. Evidence of artemisinin-resistant malaria in western Cambodia. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM, N Engl J Med 2008 359 2619 2620 10.1056/NEJMc0805011 19064625
5. WHO-GMP update on artemisinin resistance-September 2011 http://www.who.int/malaria/arupdate092011.pdf
6. Changes in susceptibility of Plasmodium falciparum to artesunate in vitro in Yunnan province, China. Yang H, Liu D, Yang Y, Fan B, Yang P, Li X, Li C, Dong Y, Yang C, Trans R Soc Trop Med Hyg 2003 97 226 228 10.1016/S0035-9203(03) 90127-1 14584382 (Pubitemid 37265638)
7. Malaria parasites can develop stable resistance to artemisinin but lack mutations in candidate genes atpase6 (encoding the sarcoplasmic and endoplasmic reticulum Ca2+ ATPase), tctp, mdr1, and cg10. Afonso A, Hunt P, Cheesman S, Alves AC, Cunha CV, do Rosário V, Cravo P, Antimicrob Agents Chemother 2006 50 480 489 10.1128/AAC.50.2.480-489.2006 16436700 (Pubitemid 43190956)
8. Artemisinins target the SERCA of Plasmodium falciparum. Eckstein-Ludwig U, Webb RJ, Van Goethem ID, East JM, Lee AG, Kimura M, O'Neill PM, Bray PG, Ward SA, Krishna S, Nature 2003 424 957 961 10.1038/nature01813 12931192 (Pubitemid 37051688)
9. A single amino acid residue can determine the sensitivity of SERCAs to artemisinins. Uhlemann AC, Cameron A, Eckstein-Ludwig U, Fischbarg J, Iserovich P, Zuniga FA, East M, Lee A, Brady L, Haynes RK, Krishna S, Nat Struct Mol Biol 2005 12 628 629 10.1038/nsmb947 15937493 (Pubitemid 40980816)
10. Drug resistance and the P-glycoprotein homologues of Plasmodium falciparum. Cowman AF, Karcz S, Semin Cell Biol 1993 4 29 35 10.1006/scel.1993.1004 8095826
11. Artemisinin resistance in Plasmodium falciparum malaria. Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NP, Lindegardh N, Socheat D, White NJ, N Engl J Med 2009 361 455 467 10.1056/NEJMoa0808859 19641202
12. Decreasing pfmdr1 copy number in Plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin. Sidhu AB, Uhlemann AC, Valderramos SG, Valderramos JC, Krishna S, Fidock DA, J Infect Dis 2006 194 528 535 10.1086/507115 16845638 (Pubitemid 44162666)
13. The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin. Duraisingh MT, Jones P, Sambou I, von Seidlein L, Pinder M, Warhurst DC, Mol Biochem Parasitol 2000 108 13 23 10.1016/S0166-6851(00)00201-2 10802315 (Pubitemid 30236312)
14. Plasmodium falciparum multidrug resistance protein 1 and artemisinin-based combination therapy in Africa. Dahlström S, Ferreira PE, Veiga MI, Sedighi N, Wiklund L, Mårtensson A, Färnert A, Sisowath C, Osório L, Darban H, Andersson B, Kaneko A, Conseil G, Björkman A, Gil JP, J Infect Dis 2009 200 1456 1464 10.1086/606009 19807279
15. Plasmodium falciparum expresses a multidrug resistance-associated protein. Klokouzas A, Tiffert T, van Schalkwyk D, Wu CP, van Veen HW, Barrand MA, Hladky SB, Biochem Biophys Res Commun 2004 321 197 201 10.1016/j.bbrc.2004. 06.135 15358235
16. Multiple transporters associated with malaria parasite responses to chloroquine and quinine. Mu J, Ferdig MT, Feng X, Joy DA, Duan J, Furuya T, Subramanian G, Aravind L, Cooper RA, Wootton JC, Xiong M, Su XZ, Mol Microbiol 2003 49 977 989 10.1046/j.1365-2958.2003.03627.x 12890022 (Pubitemid 36981343)
17. Disruption of a Plasmodium falciparum multidrug resistance-associated protein (PFMRP) alters its fitness and transport of antimalarial drugs and glutathione. Raj DK, Mu J, Jiang H, Kabat J, Singh S, Sullivan M, Fay MP, McCutchan TF, Su XZ, J Biol Chem 2009 284 7687 7696 10.1074/jbc.M806944200 19117944
18. Novel polymorphisms in Plasmodium falciparum ABC transporter genes are associated with major ACT antimalarial drug resistance. Veiga MI, Ferreira PE, Jörnhagen L, Malmberg M, Kone A, Schmidt BA, Petzold M, Björkman A, Nosten F, Gil JP, PLoS One 2011 6 20212 10.1371/journal.pone.0020212 21633513
19. Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6. Jambou R, Legrand E, Niang M, Khim N, Lim P, Volney B, Ekala MT, Bouchier C, Esterre P, Fandeur T, Mercereau-Puijalon O, Lancet 2005 366 1960 1963 10.1016/S0140-6736(05)67787-2 16325698 (Pubitemid 41713986)
20. Detection of novel point mutations in the Plasmodium falciparum ATPase6 candidate gene for resistance to artemisinins. Menegon M, Sannella AR, Majori G, Severini C, Parasitol Int 2008 57 233 235 10.1016/j.parint.2007.12.004 18187359
21. Investigations into the role of the Plasmodium falciparum SERCA (PfATP6) L263E mutation in artemisinin action and resistance. Valderramos SG, Scanfeld D, Uhlemann AC, Fidock DA, Krishna S, Antimicrob Agents Chemother 2010 54 3842 3852 10.1128/AAC.00121-10 20566762
22. Diversity of the sarco/endoplasmic reticulum Ca (2+)-ATPase orthologue of Plasmodium falciparum (PfATP6). Dahlström S, Veiga MI, Ferreira P, Mårtensson A, Kaneko A, Andersson B, Björkman A, Gil JP, Infect Genet Evol 2008 8 340 345 10.1016/j.meegid.2008.02.002 18359278
23. Geographic structuring of the Plasmodium falciparum sarco (Endo) plasmic reticulum I (PfSERCA) gene diversity. Jambou R, Martenelli A, Pinto J, Gribaldo S, Legrand E, Niang M, Kim N, Pharath L, Volnay B, Ekala MT, Bouchier C, Fandeur T, Berzosa P, Benito A, Ferreira ID, Ferreira C, Vieira PP, Alecrim MG, Mercereau-Puijalon O, Cravo P, PLoS One 2010 5 9424 10.1371/journal.pone.0009424 20195531
24. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Price RN, Uhlemann AC, Brockman A, McGready R, Ashley E, Phaipun L, Patel R, Laing K, Looareesuwan S, White NJ, Nosten F, Krishna S, Lancet 2004 364 438 447 10.1016/S0140-6736(04)16767-6 15288742 (Pubitemid 39036891)
25. Resistance to dihydroartemisinin. Cojean S, Hubert V, Le Bras J, Durand R, Emerg Infect Dis 2006 12 1798 1799 10.3201/eid1211.060903 17283645
26. In vitro assessment of artesunate, artemether and amodiaquine susceptibility and molecular analysis of putative resistance-associated mutations of Plasmodium falciparum from Sao Tomé and Principe. Ferreira ID, Lopes D, Martenelli A, Ferreira C, Rosario VE, Cravo P, Trop Med Int Health 2007 12 353 362 10.1111/j.1365-3156.2006.01789.x 17313506 (Pubitemid 46280625)
27. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Snounou G, Viriyakosol S, Zhu XP, Jarra W, Pinheiro L, do Rosario VE, Thaithong S, Brown KN, Mol Biochem Parasitol 1993 61 315 320 10.1016/0166-6851(93)90077-B 8264734
28. Selection of Plasmodium falciparum multidrug resistance gene 1 alleles in asexual stages and gametocytes by artemether-lumefantrine in Nigerian children with uncomplicated falciparum malaria. Happi CT, Gbotosho GO, Folarin OA, Sowunmi A, Hudson T, O'Neil M, Milhous W, Wirth DF, Oduola AM, Antimicrob Agents Chemother 2009 53 888 895 10.1128/AAC.00968-08 19075074
29. Dynamics of malaria drug resistance patterns in the Amazon basin region following changes in Peruvian national treatment policy for uncomplicated malaria. Bacon DJ, McCollum AM, Griffing SM, Salas C, Soberon V, Santolalla M, Haley R, Tsukayama P, Lucas C, Escalante AA, Udhayakumar V, Antimicrob Agents Chemother 2009 53 2042 2051 10.1128/AAC.01677-08 19258269
30. New PfATP6 mutations found in Plasmodium falciparum isolates from Vietnam. Bertaux L, le Quang H, Sinou V, Thanh NX, Parzy D, Antimicrob Agents Chemother 2009 53 4570 4571 10.1128/AAC.00684-09 19687249
31. Polymorphism of PfATPase in Niger: detection of three new point mutations. Ibrahim ML, Khim N, Adam HH, Ariey F, Duchemin JB, Malar J 2009 8 28 10.1186/1475-2875-8-28 19226462
32. Molecular monitoring of Plasmodium falciparum resistance to artemisinin in Tanzania. Mugittu K, Genton B, Mshinda H, Beck HP, Malar J 2006 5 126 10.1186/1475-2875-5-126 17177997 (Pubitemid 46177993)
33. Molecular epidemiology of malaria in Cameroon. XXVIII. In vitro activity of dihydroartemisinin against clinical isolates of Plasmodium falciparum and sequence analysis of the P. falciparum ATPase 6 gene. Tahar R, Ringwald P, Basco LK, Am J Trop Med Hyg 2009 81 13 18 19556559
34. No PfATPase6 S769N mutation found in Plasmodium falciparum isolates from China. Zhang G, Guan Y, Zheng B, Wu S, Tang L, Malar J 2008 7 122 10.1186/1475-2875-7-122 18606023 (Pubitemid 352001285)
35. Plasmodium falciparum from Pará state (Brazil) shows satisfactory In vitro response to artemisinin derivatives and absence of the S769N mutation in the SERCA-type PfATPase6. Ferreira ID, Martenelli A, Rodrigues LA, do Carmo EL, do Rosário VE, Póvoa MM, Cravo P, Trop Med Int Health 2008 13 199 207 10.1111/j.1365-3156.2007.01991.x 18304266 (Pubitemid 351316971)
36. Spontaneous mutations in the Plasmodium falciparum sarcoplasmic/ endoplasmic reticulum Ca2+-ATPase (PfATP6) gene among geographically widespread parasite populations unexposed to artemisinin based combination therapies. Tanabe K, Zakeri S, Palacpac NMQ, Afsharpad M, Randrianarivelojosia M, Kaneko A, Marma ASP, Horii T, Mita T, Antimicrob Agents Chemother 2011 55 94 100 10.1128/AAC.01156-10 20956593
37. Lack of association of the S769N mutation in Plasmodium falciparum SERCA (PfATP6) with resistance to artemisinins. Cui L, Wang Z, Jiang H, Parker D, Wang H, Su XZ, Cui L, Antimicrob Agents Chemother 2012 56 5 2546 10.1128/AAC.05943-11 22354307
38. In vitro susceptibility to quinine and microsatellite variations of the Plasmodium falciparum Na-/H- exchanger (pfnhe-1) gene: the absence of association in clinical isolates from the republic of Congo. Briolant S, Pelleau S, Bogreau H, Hovette P, Zettor A, Castello J, Baret E, Amalvict R, Rogier C, Pradines B, Malar J 2011 10 37 10.1186/1475-2875-10-37 21314947
39. In vitro sensitivity of Plasmodium falciparum clinical isolates from the China-Myanmar border area to quinine and association with polymorphism in the Na-/H-exchanger. Meng H, Zhang R, Yang H, Fan Q, Su X, Miao J, Cui L, Yang Z, Antimicrob Agents Chemother 2010 54 4306 4313 10.1128/AAC.00321-10 20643902
40. Targeted disruption of an erythrocyte binding antigen in Plasmodium falciparum is associated with a switch toward a sialic acid-independent pathway of invasion. Reed MB, Caruana SR, Batchelor AH, Thompson JK, Crabb BS, Cowman AF, Proc Natl Acad Sci USA 2000 97 7509 7514 10.1073/pnas.97.13.7509 10861015 (Pubitemid 30431494)
41. pfmdr1 Mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum. Sidhu AB, Valderramos SG, Fidock DA, Mol Microbiol 2005 57 913 926 10.1111/j.1365-2958.2005.04729.x 16091034 (Pubitemid 41139856)
42. Identification of a mutant PfCRT-mediated chloroquine tolerance phenotype in Plasmodium falciparum. Valderramos SG, Valderramos JC, Musset L, Purcell LA, Mercereau-Puijalon O, Legrand E, Fidock DA, PLoS Pathog 2010 6 1000887 10.1371/journal.ppat.1000887 20485514